DocGo reported a strong fourth quarter with total revenues of $199.2 million, an 83% increase compared to the previous year. Net income increased by 13% to $8.0 million, and adjusted EBITDA saw a substantial rise of 232% to $22.6 million. The company's full-year revenue increased by 42% to $624.2 million.
Total revenues for Q4 2023 were $199.2 million, an increase of 83% compared to Q4 2022.
Net income for Q4 2023 was $8.0 million, a 13% increase compared to Q4 2022.
Adjusted EBITDA for Q4 2023 was $22.6 million, a 232% increase compared to Q4 2022.
Mobile Health Services revenues in Q4 2023 increased by 110% to $150.4 million compared to Q4 2022.
DocGo expects full-year 2024 revenues to be between $720 million and $750 million and adjusted EBITDA to be between $80 million and $85 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance